Executive Summary: xLM Continuous Intelligent Validation
Strategic Partnership Opportunity with Rockwell Automation/Plex
Prepared by Nagesh Nama
CEO, xLM Continuous Intelligence
February 2nd, 2026.
60 Seconds
The Opportunity in 60 Seconds
Rockwell's Plex platform is the industry's most advanced cloud-native ERP/MES—but pharmaceutical manufacturers won't adopt it because they can't validate it under 21 CFR Part 11 and ICH Q 7.
The Problem
Traditional validation (CSV) requires full revalidation when software changes. Plex deploys updates weekly. The math doesn't work.
The FDA Shift
September 2025 CSA guidance explicitly permits risk-based, proportionate validation and endorses continuous deployment with automated testing—specifically to enable cloud SaaS adoption.
Our Solution
xLM becomes Plex's integrated validation engine.
Plex-Platform
Automated validation of Plex platform updates
Plex-Instance(s)
Continuous Validation with 100% Regression
Real-time Compliance
Provide Real-time Compliance for the Plex-Platform & Plex-Instances
The Result: Plex becomes the only continuously validated SaaS manufacturing platform for life sciences.
Market Size & Business Impact
Why Now?
FDA CSA Guidance
Creates regulatory permission for risk-based SaaS validation; However, xLM's technology can support continuous validation with 100% regression.
Life Sciences Adoption Pressure
51% of manufacturers plan smart manufacturing adoption within 5 years, constrained by validation barriers
Plex Underrepresentation
<10% of Plex's 700 customers are in life sciences (vs. 70% in discrete manufacturing)
Competitor Positioning
Window of 12-24 months to establish market-leading "validated SaaS" position before competitors respond
Three Integrated Services
1. CIV-Platform: Plex Release Validation
Problem
Life sciences customers need proof that weekly Plex updates don't introduce compliance risks.
Solution
Automated regression testing of all GxP-critical functionality (audit trails, electronic signatures, data integrity, access controls).

Business Impact: Removes single largest barrier to life sciences adoption. Converts Plex from "compliance risk" to "compliance enabler."
2. CIV-Instance: Continuous Customer Instance Monitoring
Problem
Customers need ongoing assurance their Plex configuration remains in validated state.
Solution
Continuous monitoring agents tracking system configuration, data integrity, access controls, audit trail completeness.
Business Impact
Shifts support from "how do we validate?" to self-service compliance. Deepens customer relationships. Reduces support burden.
3. Lifecycle: Change Management Automation
Problem
Configuration changes, customizations, and integrations trigger change control requirements. Manual assessment is slow and error-prone.
Solution
Automated change impact assessment, risk proportionalization, documentation generation, and post-change verification.
Business Impact
Enables rapid Plex customization with compliance confidence. Reduces change cycle time from 8-12 weeks to hours.
Implementation Timeline
Competitive Context & Timing
Why This Matters
Plex competes against Körber PAS-X, L 7 Informatics, Siemens, and Dassault. Plex's advantage: cloud-native, single-instance SaaS, global scale. But without solved validation story, these advantages are abstract.
The company that solves validated SaaS for life sciences will capture 40-50% of the market.
The Window
FDA CSA guidance creates 12-24 month first-mover advantage. If Rockwell moves decisively, it can establish market-leading position in "validated, continuously deployed manufacturing software" before competitors develop similar solutions.
Why This Works
For Rockwell
  • Unlocks $50-150 M TAM in highest-margin customer segment
  • Creates defensible competitive moat
  • Generates $10 M+ annual recurring revenue
  • Establishes Rockwell as regulatory/compliance leader in smart manufacturing
  • Accelerates Plex adoption in life sciences vertical
For xLM
  • Accesses customer base via Plex
  • Achieves distribution scale in highest-value vertical
  • Gains Rockwell credibility and go-to-market assets
For Pharma Customers
  • Adopt modern SaaS platform without validation risk
  • Reduce deployment cycle time (8-12 weeks → 2-3 weeks)
  • Gain FDA CSA-aligned compliance confidence
  • Unlock cloud-native operational benefits
Next Steps
1
Feb 3
Initial partnership framework meeting (Alex, Anthony, Devin + xLM team)
2
Step 2
Technical architecture deep-dive (engineering + product teams)
3
Step 3
Commercial terms negotiation
4
Step 4
Phase 1 kickoff (CIV-Platform for Plex 2026.03 release)
5
Step 5
White paper publication + pilot customer recruitment
6
Step 6
Phase 1 completion, market launch readiness
This proposal demonstrates that xLM and Rockwell can together own the validated SaaS manufacturing platform category for life sciences—if we move decisively in the next 12-24 months.
Schedule a Meeting
The xLM Solution: Continuous Intelligence Validation for Plex
Core Offering: Three Integrated Services
Plex Platform Continuous Intelligent Validation (CIV-Platform)
Problem: Rockwell releases updates to the Plex platform every 1-2 weeks. Life sciences customers need proof that those updates don't introduce risks to validated processes, data integrity, or regulatory compliance.
xLM Solution: Automated, continuous validation of Plex platform updates in near-real-time.
How It Works:
  • XLM integrates with Rockwell's release pipeline to ingest each Plex platform update
  • Automated regression testing suite validates all GxP-critical functionality: audit trails, electronic signatures, data integrity controls, access controls, change logs, batch record integrity
  • Risk-based testing prioritizes high-impact modules (Quality, MES, CAPA) over low-risk areas (UI cosmetics, non-GxP reporting)
  • For each release, xLM generates a validation summary documenting: what changed, what was tested, what risks were assessed, and what assurance level was achieved
  • Customers receive a pre-validated "Plex release readiness" certification
Business Impact for Rockwell:
  • Removes the single largest barrier to Plex adoption in life sciences
  • Converts Plex from a "compliance risk" to a "compliance enabler"
  • Eliminates customer hesitation about SaaS deployment frequency
Customer Instance Continuous Intelligent Validation (CIV-Instance)
Problem:
Life sciences customers need ongoing proof that their specific Plex configuration—with custom workflows, integrations, and data—remains in validated state as they operate and as Plex platform updates deploy.
xLM Solution:
Continuous monitoring and validation of customer Plex instances.
How It Works:
  • XLM deploys monitoring agents into customer Plex environments (cloud-hosted, with zero access to product/manufacturing data)
  • Continuous surveillance tracks: system configuration drift, unauthorized changes, integration failures, data integrity anomalies, access control violations, audit trail completeness
  • Automated remediation triggers for low-risk issues; compliance alerts for high-risk findings
  • Monthly validation reports document system state, any deviations, and remediation actions
  • Integrates directly with customer Quality Management Systems to auto-populate compliance documentation
Business Impact for Rockwell:
  • Shifts customer support burden from "how do we validate this?" to automated, self-service assurance
  • Deepens customer relationship through ongoing compliance partnership (vs. One-time implementation)
  • Reduces customer escalations and support costs
  • Enables Rockwell to confidently recommend Plex to customers with the most stringent compliance needs
Lifecycle: Change Management Automation
Change and CSPA Lifecycle Management (Continuous CSPA Lifecycle)
Problem: Configuring Plex, customizing workflows, or integrating with other systems triggers essential change control and impact assessment. Manually evaluating each change is resource-intensive and prone to errors.
xLM Solution: Automated change impact assessment and CSPA (Change Sustainability and Performance Assessment) for all Plex-based modifications.
How It Works:
  • XLM integrates directly with Plex's change control and configuration management modules.
  • When a configuration change, workflow modification, or integration is proposed, xLM automatically analyzes its scope and risk.
  • It identifies all impacted systems, data flows, and processes.
  • XLM recommends appropriate testing and validation activities and generates detailed impact assessment documentation.
  • It monitors implementation and verifies post-change integrity.
  • The solution fully integrates with Plex's document control for electronic signatures and audit trails.
Business Impact for Rockwell:
  • Empowers customers to configure and update Plex with confidence.
  • Significantly reduces time-to-value for new capabilities and customizations.
  • Automates compliance documentation, transforming a compliance cost center into a value-adding asset.
Disclaimer
This proposal is confidential and intended solely for Rockwell Automation's leadership team. Unauthorized distribution is prohibited.
All financial projections and ROI estimates are based on typical xLM client results and industry benchmarks. Actual results may vary based on Rockwell Automation's specific operational context.
xLM Continuous Intelligence reserves the right to update this proposal based on additional discovery and alignment discussions with Rockwell Automation.